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ABSTRACT OF THE THESIS 
 
Cognitive Function in the Alcohol Addiction Treatment Population 
 
by 
 
Suranee Abeyesinhe 
Doctor of Philosophy Graduate Program in Clinical Psychology 
Loma Linda University, September 2014 
Dr. Jason E. Owen, Chairperson 
 
Chronic alcohol abuse has been linked to several cognitive deficits, such as 
problems with spatial processing, decreased executive functioning, impaired verbal 
fluency, poor working memory, response inhibition, and social problems such as 
aggression and social deviance. In order for patients to benefit from treatment, they must 
be able to utilize multiple cognitive functions. Research has shown that patients suffering 
from cognitive impairments are much more likely to drop out of treatment early, thereby 
lending them to higher relapse rates. This study aimed to identify cognitive deficits 
present in the alcohol addiction treatment population, demographic factors associated 
with higher levels of cognitive deficits, and whether these patients’ cognitive deficits 
predict treatment dropout. Results of this study indicated that patients in the addiction 
treatment program at the LLUBMC evidenced reductions in visuospatial abilities, 
immediate memory, delayed memory, and overall cognitive function. Further, in this 
population, below average delayed memory significantly predicted treatment dropout.  
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CHAPTER ONE 
INTRODUCTION 
 
 
Over 17 million people in the United States are alcoholics or suffer from alcohol 
abuse problems (NIH).  Alcoholism can lead to a variety of different problems, including 
social, psychological, cognitive, and medical ailments. In 2009 alone, alcohol abuse 
treatment made up 42% of the near 2 million substance abuse admissions into treatment 
programs. Further, relapse rates in this population remain relatively high; research 
findings vary depending on the definition of relapse. With the various implications 
alcohol addiction and abuse create on society, it is important for us to study the cycle of 
addiction, as well as the cognitive deficits that may impact treatment completion and 
efficacy.  
 There are many neurobiological and social factors that interact in the cycle of 
addiction. Neurobiologically speaking, there are several neurotransmitters that positively 
reinforce the effects of alcohol use. Social factors magnify these effects, making it very 
difficult for an individual to break the cycle of addiction. Effective addiction treatment 
may be the only solution for many people suffering from alcoholism or alcohol abuse.  
 Currently, there are a number of treatment modalities that have been shown to be 
effective. The Minnesota Model, Cognitive Behavioral Therapy, Motivational 
Enhancement Therapy, and Twelve-step Facilitation are some of the most commonly 
used addiction treatments. Although these treatments have been shown to have positive 
results, there is no modality of treatment that directly targets the cognitive deficits 
experienced by those individuals suffering from alcohol addiction.  
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 Chronic alcohol abuse has been linked to several cognitive deficits, such as 
problems with spatial processing, decreased executive functioning, impaired verbal 
fluency, poor working memory, response inhibition, and social problems such as 
aggression and social deviance. In order for patients to benefit from treatment, they must 
be able to utilize multiple cognitive functions. It has been shown that patients suffering 
from cognitive impairments are much more likely to drop out of treatment early, thereby 
lending them to higher relapse rates.  
 This study aims to identify the most commonly presented cognitive deficits in the 
alcohol addiction treatment population. We also aim to explore demographic factors that 
may be associated with higher levels of cognitive deficits. Finally, we will examine 
whether patients’ cognitive deficits have an effect on completion of the treatment 
program at the Loma Linda Behavioral Medical Center. By identifying specific cognitive 
deficits present in this population, a more tailored treatment plan may be implemented in 
the future in order to increase treatment completion and reduce relapse rates.  
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CHAPTER TWO 
BACKGROUND 
 
The National Institute on Drug Abuse has defined addiction as a “chronic 
relapsing disease characterized by compulsive drug-seeking and abuse and by long-
lasting chemical changes in the brain.” Generally, there are genetic, psychosocial, and 
environmental factors that contribute to the development of this disease.  
The following tables from the DSM-IV describe the criteria for substance abuse and 
substance dependence:  
 
 
Table 1 
DSM Criteria of Substance Abuse  
A maladaptive pattern of substance use leading to clinically significant 
impairment or distress as manifested by one (or more) of the following, occurring 
within a 12-month period: 
1. Recurrent substance use resulting in a failure to fulfill major role obligations at 
work, school, or home 
2. Recurrent substance use in situations in which it is physically hazardous 
3. Recurrent substance-related legal problems 
4. Continued substance use despite having persistent or recurrent social or 
interpersonal problems caused or exacerbated by the effects of the substance 
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Table 2 
DSM Criteria of Substance Dependence  
Substance dependence is defined as a maladaptive pattern of substance use leading 
to clinically significant impairment or distress, as manifested by three (or more) of 
the following, occurring any time in the same 12-month period: 
1. Tolerance, as defined by either of the following: (a) A need for markedly 
increased amounts of the substance to achieve intoxication or the desired effect 
or (b) Markedly diminished effect with continued use of the same amount of 
substance. 
2. Withdrawal, as manifested by either of the following: (a) The characteristic 
withdrawal syndrome for the substance or (b) the same (or closely related) 
substance is taken to relieve or avoid withdrawal symptoms. 
3. The substance is often taken in larger amounts or over a longer period then 
intended. 
4. There is a persistent desire or unsuccessful efforts to cut down or control 
substance use. 
5. A great deal of time is spent in activities necessary to obtain the substance, use 
the substance, or recover from its effects. 
6. Important social, occupational, or recreational activities are given up or 
reduced because of substance use. 
7. The substance use is continued despite knowledge of having a persistent 
physical or psychological problem that is likely to have been caused or 
exacerbated by the substance 
 (DSM–IV–TR (2000) 4th ed., text rev.).  
 
 
Alcohol addiction can cause a number of medical, social, and psychological 
problems. According to the Center for Disease Control, immediate risks associated with 
excessive alcohol use include unintentional injuries such as car accidents, falls, drowning, 
and firearm injuries; alcohol poisoning; violence, such as domestic disputes and child 
maltreatment; risky sexual behaviors; miscarriages and birth related defects. Long term 
risks associated with excessive alcohol use can lead to the development of chronic 
diseases, neurological problems, and social problems.  
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Scope of the Problem 
 The economic cost of drug abuse in 2002 was estimated at $180.9 billion.  This 
value represents both the use of resources to address health and crime consequences as 
well as the loss of potential productivity from disability, death and withdrawal from the 
workforce. Further, alcohol related arrests have significantly contributed to the doubling 
of the nation's incarceration rate since 1985.  Risk for relapse is high and maybe even 
higher among sensitive subpopulations such as those presenting to treatment with 
complex comorbidities (Office of National Drug Control Policy).   
According to the United States Substance Abuse and Mental Health Services 
Administration (SAMHSA) in 2009, almost 2,000,000 substance abuse treatment 
admissions for people aged 12 and older were reported in the United States. Five major 
substance groups accounted for 96 percent of these 2 million admissions: alcohol (42%), 
opiates (21%), marijuana (18%), cocaine (9%), and methamphetamines/amphetamines 
(6%). The average age at admission was 34 years, with non-Hispanic Whites making up 
60 percent of all treatment admissions (followed by Blacks at 21%, Hispanics at 14%, 
and other racial groups at 5%). There was no significant difference in gender at 
admission; females made up 51 percent of admissions, males made up 49 percent.  
Relapse rates for addictive diseases are usually in the range of 50% to 90%; 
however, these rates vary by definition of relapse, severity of addiction, which drug of 
addiction, length of treatment, and elapsed time from treatment discharge to assessment, 
as well as other factors (National Institute on Drug Abuse). A study by Dawson et al. 
(2007) found that 25% of alcohol dependent subjects had relapsed in a 3-year follow up 
from an abstinence based treatment program, as evidenced by a recurrence of any alcohol 
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use disorder symptoms.  Another study found that one-third of people who enter 
treatment trials are in full remission from alcohol dependence during the following year 
(Miller et al. 2001). These figures apply to those who actually enter and participate in 
treatment, and ignore the majority of alcohol dependent people who do not utilize a 
treatment program to gain sobriety. A study by Dawson et al. (2006) stated that about 
three-quarters of people with alcohol dependence reduce or stop drinking without any 
kind of professional treatment or interaction in support groups such as AA. This is an 
important consideration to make, as relapse rates among this population are not likely 
evaluated.   
 
Neurobiology of Addiction 
Addiction has been conceptualized as a chronic, relapsing disorder with roots in 
both impulsivity and compulsivity, with neurobiological mechanisms that influence how 
an individual moves through the addiction cycle. The typical behavioral cycle progresses 
as such: binge/intoxication, withdrawal/negative affect, and preoccupation/anticipation. 
Impulsivity and compulsivity can coexist at different stages of this cycle (Koob, 2009). 
Further, five specific systems of neurotransmitters have been identified as playing a part 
in the positive reinforcing effects of alcohol use: dopamine, opioid peptides, -
aminobutyric acid, glutamate, and endocannabinoids.  
The cycle of addiction involves an activation of brain pleasure centers, which 
involve these different neurotransmitters. First, upon ingesting the drug of choice, there is 
an increase in extracellular dopamine levels in the nucleus accumbens. Once experienced, 
drug euphoria promotes the repeated use of the addictive drug, especially if genetic traits 
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enhance the pleasurable effect. Evidence shows that in those with a genetic predisposition 
toward alcoholism, there may be an exaggerated -endorphin response, leading to a 
greater experience of pleasure. Over time, addictive drugs disrupt reward circuits and 
produce states of withdrawal and craving, which provide negative feedback, leading to 
drug-seeking behavior. Craving is a phenomena that can be amplified by stimuli that have 
become associated with drugs through conditioning. Neuroimaging has shown a link 
between cue-induced craving and brain function, which is arguably the most persistent 
and insidious clinical component of addiction (Dackis & O’Brien, 2005).  
 Other neuroimaging studies of brains of individuals with alcohol use disorders 
show increases in ventricular and sulcal cerebrospinal fluid volumes, suggesting a 
corresponding loss of cerebral tissue. Further studies have found associations between 
ventricular enlargement and poor performance on neuropsychological measures (Jernigan 
& Ostergaard, 1995). Magnetic resonance imagery (MRI) studies have also been 
conducted among alcoholics, and have shown loss of volume of the grey and white 
matter, especially in the prefrontal region (Sullivan, 2005). PET imaging has similarly 
been used to visualize the damage that heavy alcohol consumption has on the living 
brain. A study by Wong et al. (2003) found deficits in alcoholics, particularly in the 
frontal lobes, which are responsible for numerous functions associated with learning and 
memory, as well as in the cerebellum, which controls movement and coordination.  
 
Impact of Alcohol on Cognitive Functions 
It is important to distinguish between deficits that occur during alcohol 
intoxication, and those that persist after the effects of alcohol have worn off, especially in 
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those who abuse the substance. During intoxication, common symptoms experienced 
include impaired memory, slowed reaction times, slurred speech, blurred vision, poor 
judgment, and difficulty walking. For most individuals, these impairments subside after 
drinking has stopped. However, those who drink heavily over long periods of time may 
experience deficits that persist well after sobriety is achieved.  
There are many factors that contribute to the extent to which alcohol affects the 
brain. Some of these factors include how much and how often alcohol is consumed, how 
old the person was when he or she started drinking, whether he or she was exposed 
prenatally to alcohol, familial history of alcoholism, demographic variables, and general 
health status. It has been found that older age, lower education, health problems, 
psychiatric diagnoses, familial alcoholism, and duration of heavy drinking, have been 
inversely related to neuropsychological ability (Bates et al., 2006).   
Chronic alcohol abuse has been linked to several cognitive deficits that affect 
aspects of everyday life. Some of these include deficits in spatial processing (Fein et al., 
2006), decreased executive functioning (Glass et al., 2009), and impaired verbal fluency 
and decision making (Fernandez-Serrano et al., 2010). Other behavioral disturbances that 
occur with alcohol use include increased impulsivity and aggression (Bjork et al., 2004) 
and proneness to social deviance and disadvantageous decision making (Fein et al., 
2004).  
Cummings (1995) examined the relationship between structural and functional 
damage to the prefrontal and temporal brain areas and related circuits in heavy drinkers 
and the neuropsychological deficits associated with these areas to be significant, as they 
are responsible for memory, strategic planning, use of environmental feedback, working 
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memory, goal-setting, and response inhibition.  These functions play a major role in 
treatment outcome, as these abilities are necessary for patients to be successful in alcohol 
addiction recovery.  
Further, when examining neurocognitive deficits in sober alcoholics compared to 
peer nonalcoholic controls, Parsons (1998) found that both male and female alcoholics 
had deficits on tests of learning, memory, abstracting, problem-solving, perceptual 
analysis and synthesis, speed of information processing, and efficiency.  
In order to examine the genetic influence on alcohol related cognitive deficits, 
Gurling et al. conducted a monozygotic twin study in 1991. This study found that a twin 
with high alcohol consumption performed significantly worse overall on cognitive tests 
than their co-twin. Specifically impaired were visual spatial ability and recognition, 
vocabulary, category sorting, and tactual performance. Further, the number of years of 
problem drinking was correlated with lower scores on subtests of tactual performance. 
   
Recovery of Function 
Some of the most severe impairments associated with heavy alcohol consumption 
may resolve soon after drinking stops, however some functions may take months or even 
years to recover. Manning et al. (2008) conducted a study on neuropsychological changes 
that occur in patients after alcohol detoxification. They found that there were significant 
increases in post-detoxification scores on measures of working memory, verbal fluency, 
and verbal inhibition, but not in non-verbal executive function tasks, such as mental 
flexibility and planning ability. 
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Current Addiction Treatment 
The most used addiction treatment modalities are the following:  
The Minnesota Model takes a holistic approach, involving a multidisciplinary 
team of professionals (physicians, nurses, psychologists, social workers, and clergy) and 
recovering staff members (counselors). It combines the foundational knowledge of 
recovery with the Alcoholics Anonymous (AA) 12 steps and principles. Treatment 
consists of individual interviews, small group therapy, psychoeducation, and AA stories 
of recovery. In this model, connections with AA groups and community members were 
seen as crucial for maintaining sobriety post-treatment (Anderson, 1999).  
Cognitive Behavioral Therapy (CBT) seeks to help patients recognize, avoid, and 
cope with the situations in which they are most likely to abuse substances. It focuses on 
teaching skills such as drink refusal and relapse prevention.  
  Motivational Enhancement Therapy (MET) focuses on addressing ambivalence 
about and motivation to change.  
Twelve Step Facilitation (TSF) focuses on teaching that alcoholism is a disease 
that requires abstinence and affiliation with Alcoholics Anonymous (AA).  
Project MATCH, a clinical trial by the NIAAA that examines patient-treatment 
interactions, found that for the most part, CBT, MET, and TSF all had highly similar and 
positive results (Project MATCH Research Group 1998). However, a study conducted by 
Bates et al. (2005) found that individuals who were assigned to TSF showed more 
improvement in latent executive ability compared to those assigned to CBT and MET. 
The rationale given was that the techniques of TSF may have contributed to cognitive 
recovery by increasing the likelihood of sustained abstinence by breaking down complex, 
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long-term goals into small manageable subgoals, allowing clients to accumulate a history 
of success.   
Alcohol addiction treatment is a complicated process, incorporating many 
different psychological, social, and medical aspects. In order for treatment to be effective, 
there are key elements that must be met. In a study conducted by Kellogg and Tatarsky 
(2010), 25 clinicians in New York convened at a roundtable to discuss what psychosocial 
factors play a part in successful treatment for addictions. There was agreement that 
treatment plans should be individually specific and emphasize improving patients’ sense 
of self-efficacy. Further, the relapse prevention model was almost universally endorsed. 
The group of clinicians also endorsed the idea that long-term recovery is dependent on 
embracing new personal and social identities that replace those that were based on their 
substance use.  
 
Cognitive Deficits and Treatment Efficacy and Outcomes 
 Why is it important to examine cognitive deficits in the addiction population? 
Research on drug abuse, including alcohol use, has yielded findings suggesting that in 
order for patients to initiate and maintain behavioral change, they must be able to utilize 
multiple cognitive functions (Weinstein & Shaffer, 1993); users with cognitive 
impairments are much more likely to drop out of treatment early, and show less 
engagement in the treatment process (Aharonovich et al., 2006; Teichner et al., 2002). 
Another study found that greater cognitive impairment predicted less treatment 
compliance, and lower self-efficacy, in turn, predicting drinking outcomes, with less 
treatment and lower self-efficacy leading to fewer days of abstinence and more drinks per 
 12 
drinking day (Bates et al., 2006).  
A study by Blume et al. (2005) investigated stage of change and cognitive factors 
in an alcohol dependent population. They found that lower verbal and higher delayed 
recall memory scores predicted a precontemplative stage of change, whereas higher 
verbal memory scores predicted a contemplative stage of change. Further, better attention 
and concentration predicted reduced drinking at a 3-month follow up.  
 Currently, there are few studies documenting specific cognitive deficits 
experienced by those abusing alcohol. However, there are even fewer studies that address 
how these deficits influence treatment outcomes. This study aims to investigate this 
relationship, hypothesizing that those patients with more severe cognitive deficits will 
have poorer treatment outcomes. Clinically, this may be useful in devising new treatment 
protocols that can target and enhance individual’s cognitive deficits, directly improving 
treatment outcomes.  
 
Confounding Factors 
 A few variables have been identified as confounding factors to cognitive 
functions. Some of these include previous traumatic brain injury, familial alcoholism, 
childhood behavioral problems, psychopathology, and ongoing medical issues (Bates, 
2002). A study conducted by Miller (1995) found that the prevalence of alcohol and drug 
use disorders is more than 50% among head trauma victims. Head trauma alone lends 
itself to a host of cognitive deficits, and paired with alcohol use, these deficits may be 
even more detrimental to an individual. It is important to assess for previous head trauma, 
 13 
in the likelihood that it either serves as a risk factor for alcohol abuse and/or is 
responsible for some variance of measured cognitive functions.  
 
Clinical Implications 
Cognitive rehabilitation may enhance current addiction treatment modalities. It 
can address deficits in attention, memory, learning, and problem solving, enabling a 
patient to engage and utilize treatment strategies more effectively. Fals-Stewart and Lam 
(2010) found that patients who underwent computer-assisted cognitive rehabilitation in 
addition to standard treatment were more engaged and committed to treatment, and 
reported better long-term outcomes (higher percentage of days abstinent after treatment).  
 
 
Aims and Hypotheses 
 
The first aim of this study will be to identify the cognitive deficits present in 
alcohol addiction treatment patients. The hypothesis is that participants will have below 
average scores on all five domains and overall score on the RBANS.  
The second aim of this study is to evaluate the effect of demographic variables on 
cognitive function. The hypothesis is that lower income, fewer years of education, 
heavier drinkers, and those who began drinking at a younger age will have poorer 
cognitive function.  
The third aim of this study will be to  evaluate the relationship between cognitive 
deficits and treatment completion. The hypothesis is that those with poorer cognitive 
performances will have poorer treatment completion rates.  
The fourth, and final, aim of this study will be to evaluate how other risk factors 
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such as comorbid mental health diagnosis and prior termination of rehabilitation 
programs affect treatment completion. The hypothesis is that those with comorbid mental 
health diagnoses and/or prior treatment termination will have poorer rates of treatment 
completion.  
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CHAPTER THREE 
MATERIALS AND METHODS 
 
 
Participants 
 
Participants will be recruited from consecutive admissions to an intensive 
outpatient chemical dependency treatment program at the Loma Linda Behavioral 
Medical Center (LLUBMC). All participants will be detoxified at the LLUBMC, and will 
be medically stable at outpatient treatment entry. Participants aged 20-89 will be included 
in the study.  
 
Procedure 
Participants of the chemical dependency treatment program will be recruited for 
the study during their first week at the LLUBMC. Once the patient has completed the 
inpatient detoxification program, he/she enters the outpatient partial hospitalization 
program, and will be approached to participate in this study.  Informed consent will be 
obtained by a trained clinical researcher (explaining the study aims, design, and 
risks/benefits), and signed documents will remain in a secured office. A verbal survey 
will also be given to the participants at the time of consent. This survey will include 
questions regarding history of alcohol use, severity, and at what age the subject began 
drinking. Issues regarding familial alcoholism, childhood behavioral issues, 
psychopathology, previous head trauma, and medical issues will also be assessed. See 
Appendix A. During their first two days of the outpatient program, consenting patients 
will be given a brief neuropsychological battery, the Repeatable Battery for the 
Assessment of Neuropsychological Status (RBANS).  
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Instruments 
A survey collecting demographic information, alcohol use history, and 
confounding factors will be verbally administered (see Appendix A).  
The RBANS is a brief, individually administered test that helps to determine the 
neuropsychological status of adults who have neurologic injury or disease. The test 
consists of five indexes: immediate memory, visuospatial/constructional, language, 
attention, and delayed memory. There are 12 subtests of the RBANS, including: list 
learning, story memory, figure copy, line orientation, digit span, symbol digit coding, 
picture naming, semantic fluency, list recall, list recognition, story recall, and figure 
recall. The total scale score provides a global measure of neuropsychological functioning. 
The RBANS utilized a United States population-based normative standardization, and 
data are scaled using age-based norms and percentiles.  
The overall battery takes about 30 minutes to administer, creating a time frame 
that maximizes patient cooperation and minimizes effects of fatigue on performance. The 
RBANS was also designed to bridge the gap in cognitive assessment, being sensitive to 
mild impairment as well as severe dementia, enabling its use for normal older adults as 
well (Randolph, 1998). The RBANS has two parallel forms, which is ideal for measuring 
change in the patient’s neuropsychological status over time. This measure was originally 
used as a tool to assess dementia in elderly patients, however it has demonstrated clinical 
utility amongst a wide range of neuropsychological and psychiatric populations, such as 
with traumatic brain injury (McKay et al., 2007), schizophrenia and bipolar disorder 
(Dickerson et al., 2004), and anorexia nervosa (Mikos et al., 2008). It was also used in a 
study that assessed cognitive ability in college athletes that participated in contact sports 
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(Killam et al., 2005). In the addiction population, the RBANS has been used with 
veterans residing in a substance abuse treatment program, and indicated post-treatment 
increases in immediate memory and attention (Schrimsher and Parker, 2008). Curry and 
Stasio (2009) also used the RBANS in a study evaluating the effects of alcohol and 
energy drinks on neuropsychological performance, finding deficits in 
visuospatial/constructional and language performance scores.  
Scoring for the RBANS is as follows: each subtest yields a subtest raw score. 
These scores are then transferred to a score summary sheet that combines subtests into 
the specified domains, yielding an index score. Each index score will also be converted to 
percentile scores, utilizing the age-based normative conversions provided in the RBANS 
manual.  
 
Variables to be Examined 
Demographic Data 
 Age, gender, years of education, and income will be collected from the 
multidisciplinary patient assessment conducted at intake to the chemical dependency 
program. Education will be coded as a continuous variable. Income will be coded as a 
categorical variable with the following values: <10k, 10-35k, 35-60k, 60-80k, and 80k+.  
 
Substance Abuse History 
 Information regarding substance abuse history will be collected from the verbal 
survey given to the participants at the time of consent.  The variables of interest are age at 
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first drink, and general number of drinks consumed in one sitting during heaviest period 
of drinking. Both variables will be coded as continuous variables.  
 
Cognitive Function 
 Five domains of neuropsychological functioning will be assessed by the RBANS. 
Each domain consists of two subtests, with the exception of the delayed memory domain, 
which has four subtests. Each of the following domains will be evaluated:  
 
Immediate Memory 
 
 This domain measures one’s ability to remember a small amount of information 
immediately after it is presented. In order to test this domain, the following subtests of 
the RBANS are used.  
List Learning 
This consists of a list of 10 unrelated words, read for immediate recall over four 
trials, for a total maximum score of 40. The words are of moderate-high imagery and low 
age-of-acquisition, thereby reducing possible education effects on performance and 
easing translation. 
Story Memory 
This consists of a 12-item story, read for immediate recall over two trials, for a 
total maximum score of 24. Scoring is based upon verbatim recall, and the stories 
contained in the different forms of the RBANS follow the same basic structure. 
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Visuospatial Ability 
 This domain allows one to analyze, understand, and recreate spatial relations. For 
example, this includes ability to mentally rotate objects, estimate distance and depth, and 
navigate the surrounding environment. The following RBANS subtests are used to 
evaluate this domain.  
Figure Copy 
This consists of the direct copy of a complex geometrical figure, similar to the 
Rey-Osterrieth figure, but somewhat less demanding. There are 10 components of the 
figure, and a structured simplified scoring guide (contained on the record form) yields a 
maximum score of 20. There is an additional detailed scoring guideline and associated 
transparency available as of 2008 to improve inter-rater reliability in scoring this subtest 
(this is the only subtest for which scoring is not entirely objective).  
Line Orientation  
Subjects are shown an array of 13 lines, fanning out from a common point of 
origin through 180 degrees. For each item, two target lines are shown beneath the array, 
and subjects must identify which lines they match within the array. There are 10 items, 
each containing two lines to be matched, for a total maximum score of 20.  
 
Language 
 This domain includes one’s ability to acquire and utilize a system of 
communication, and the ability to respond verbally to naming or retrieving learned 
material.  The following subtests examine this domain.  
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Picture Naming 
This is a confrontation naming task, with 10 line drawings of objects that must be 
named by the subject. 
Semantic Fluency  
Subjects are given 60” to provide as many exemplars as they can from a given 
semantic category (e.g., fruits and vegetables).  
 
Attention 
 This domain evaluates one’s ability to select a subset of information to focus on 
for enhanced processing and integration. It examines the examinee’s capacity to 
remember and manipulate both visually and orally presented information in short-term 
memory storage. The following two subtests make up this domain.  
Digit Span 
This is a classic digit repetition test of working memory, with stimulus items 
increasing in length from 2 digits to 9 digits. Items are administering in order of length, 
and the test is discontinued after failure of two items at a given string length. 
Coding 
This processing speed subtest is very similar to the Digit Symbol subtest of the 
Wechsler scales. Subjects must fill in digits corresponding to shapes as quickly as they 
can on the basis of a coding key. After completing practice items, subjects have 90” to 
complete as many items as they can.  
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Delayed Memory 
 This domain explores one’s ability to remember information after a period of 
time. In order to test this domain, these subtests are given to participants 20 minutes after 
original presentation.  
List Learning Free Recall 
Free recall of the words from the initial List Learning subtest (max=10). 
List Learning Recognition  
Yes/No recognition for the words from List Learning, with 10 foils (max=20). 
Story Memory Free Recall 
Free recall of the story from the Story Memory subtest (max=12). 
Figure Free Recall 
Free recall of the Figure from the Figure Copy subtest (max=20).  
 
Total Score 
This score is a combination of all domain scores that represents a global measure 
of neuropsychological functioning.  
 
Completion of Treatment 
 A binary variable will be created in order to evaluate whether subjects completed 
the intensive outpatient treatment.  
 
Planned Analyses 
 
The first aim of this study will be to identify the cognitive deficits present in 
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alcohol addiction treatment patients. The hypothesis is that participants will have below 
average scores on all five domains and overall score on the RBANS. The analyses that 
will be conducted to evaluate this hypothesis will include: computing subtest and index 
scores using RBANS normative data, descriptive data analysis in order to see most 
common deficits, Welch’s t-tests to investigate significant differences between sample 
and normative performances on each subtest, and one-sample t-tests to evaluate whether 
the group index scores are significantly different from an average index score of 100.  
The second aim of this study is to evaluate the effect of demographic variables on 
cognitive function. The hypothesis is that lower income, fewer years of education, 
heavier drinkers, and those who began drinking at a younger age will have poorer 
cognitive function. The analyses to be performed for this hypothesis will include six 
stepwise linear regressions (one for each domain and overall score on the RBANS), with 
the independent variables including income, education, severity of drinking, and age at 
first drink, and the dependent variable being each cognitive domain index score.  
The third aim of this study will be to  evaluate the relationship between cognitive 
deficits and treatment completion. The hypothesis is that those with poorer cognitive 
performances will have poorer treatment completion rates. Logistic regressions will be 
utilized to test this hypothesis. In each of the six regressions, the independent variable 
will be each cognitive domain index score, and the dependent variable will be the 
dichotomous treatment completion variable.  
The fourth, and final, aim of this study will be to evaluate how other risk factors 
such as comorbid mental health diagnosis and prior termination of rehabilitation 
programs affect treatment completion. The hypothesis is that those with comorbid mental 
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health diagnoses and/or prior treatment termination will have poorer rates of treatment 
completion. Two separate logistic regressions will be performed. To investigate the effect 
of mental health on treatment completions, the regression will include mental health 
comorbidity as the independent variable, and completion of treatment as the dependent 
variable. In order to investigate the effect of prior termination of treatment, a sub-dataset 
will be created for only those who attended a previous addiction treatment program. 
Using this sub-dataset, a logistic regression will be utilized, with prior dropout being the 
independent variable, and treatment completion as the dependent variable.  
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CHAPTER FOUR 
 
RESULTS 
 
 
Statistical Analyses 
The primary outcome measure was completion of treatment. Risk factors of 
primary interest were individual’s index scores for the following cognitive domains: 
attention, language, visuospatial, immediate memory, delayed memory, and overall 
cognitive functioning. Also of interest were demographic factors (age, gender, race, 
marital status, education, income), severity of consumption (drinks per sitting, age at first 
drink), comorbid mental health diagnoses, and prior treatment dropout. For the analyses 
conducted, a p value of 0.05 was considered significant, and a 95% confidence interval 
(CI) was used. The computer statistical software package SPSS (version 22) was used for 
all analyses. GraphPad software was also utilized for Welch’s unpaired t-test analyses.   
 The cognitive domain variables were also transformed from index score variables 
into dichotomous ability classification variables (below average vs. average and above) 
for ancillary analyses in order to further examine their effects.  
 
Patient Population 
Patients admitted to the outpatient Chemical Dependency Partial Hospitalization 
Program (PHP) at the LLUBMC from May of 2013 through March 2014, with a primary 
alcohol abuse diagnosis were considered in the final analysis. 2 patients were excluded 
due to missing information. The total number of patients included in this data analysis 
amounted to 25.   
The clinical characteristics of patients enrolled in the Chemical Dependency PHP 
 25 
are shown in Table 3. Information on age, gender, race, marital status, education, and 
income were assessed upon admission. The average age at admission was 46.3. Males 
made up the majority of the treatment population, constituting 56% of the patient pool. 
The ethnic majority of this population was Caucasian (56%), and 60% of patients were 
married. Patient’s educational background varied, with 40% of patients having a high 
school diploma or GED, 28% completing some college, 24% completing a Bachelor’s 
degree, and 2 patients (8%) held graduate level degrees. About half of the patients 
reported an annual income of over $80,000, followed by 40% of patients making between 
$35,000-$80,000, and only 3 (12%) of patients making less than $35,000 a year. In 
regard to treatment completion, 16 out of 25 patients (64%) completed treatment.  
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Table 3 
Descriptive Statistics for the LLUBMC patient population  
Total N = 25 N (%) 
Gender 
    Male 
    Female 
14 (56) 
11 (44) 
Race 
    Caucasian 
    Hispanic 
    African American 
    Asian 
    Other 
 
14 (56) 
7 (28) 
1 (4) 
1 (4) 
2 (8) 
Marital Status 
    Married 
    Separated 
    Divorced 
    Single 
15 (60) 
3 (12) 
2 (8) 
5 (20) 
Education 
   High School 
    Some College 
    Bachelor’s 
    Master’s/Doctorate 
 
10 (40) 
7 (28) 
6 (24) 
2 (8) 
Income 
    <10k 
    10-35k 
    35-60k 
    60-80k 
    80k+ 
 
1 (4) 
2 (8) 
5 (20) 
5 (20) 
12 (48) 
  
 Mean  
Age 46.3 
 
 
 
Cognitive Deficits Among Patients 
 
The first hypothesis of this study was that the patients undergoing alcohol 
addiction treatment will have poorer cognitive functioning than the general population.  
In order to evaluate the profile of cognitive deficits present within this sample, a 
frequency analysis was conducted in order to identify frequencies of individual’s index 
scores on each cognitive domain. In conjunction with standard neuropsychological 
cutoffs that identify scores equivalent to 1 standard deviation below the mean to signify 
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reduced functioning, the number of patients in this population that scored in the below 
average range, and the sample means by domain, are depicted in Table 4 below.  
 
 
Table 4 
Cognitive Deficits Among Participant Sample 
Cognitive 
Domain 
Attention Language Visuospatial 
Immediate 
Memory 
Delayed 
Memory 
Total 
Mean of Index 
Score 
97.72 98.32 91.84 92.2 93.84 92.76 
       
 N (%) N (%) N (%) N (%) N (%) N (%) 
Below 
Average 
6 (24) 3 (12) 7 (28) 10 (40) 6 (24) 8 (32) 
 
 
In regard to attention, 24% of the participants scored below average. On the test 
of language abilities, 12% performed below average. In regard to visuospatial 
functioning, 28% of the participants scored below average. On tests of memory, 40% of 
participants scored below average on immediate memory, and 24% of participants scored 
below average on delayed memory. Finally, participants’ overall cognitive function was 
also evaluated and 32% of participants scored in the below average range.  
 
 
Normality of Distributions 
 
To further investigate the normality of the distributions present in this sample, 
Shapiro-Wilk tests of normality, skew, and kurtosis analyses were run. According to 
these analyses, this sample’s performance did not significantly differ from a normal 
distribution. See Tables 5 and 6 below. 
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Table 5 
Shapiro-Wilk Tests of Normality  
Cognitive Domain Statistic df p 
Attention .929 25 .084 
Language .952 25 .271 
Visuospatial .974 25 .755 
Immediate Memory .971 25 .660 
Delayed Memory .967 25 .565 
Overall Cognitive Function .957 25 .360 
 
 
 
Figures 1 through 6 below illustrate the distributions present in this sample on 
each domain of the RBANS, including a normal distribution curve for reference.  
 
 
Figure 1. Bar graph showing this sample’s performance on 
the Attention domain compared to a normal distribution 
curve.  
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Figure 2. Bar graph showing this sample’s performance on 
the Language domain compared to a normal distribution 
curve.  
 
Figure 3. Bar graph showing this sample’s performance on 
the Visuospatial domain compared to a normal distribution 
curve.  
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Figure 4. Bar graph showing this sample’s performance on the 
Immediate Memory domain compared to a normal distribution 
curve.  
 
 
 
Figure 5. Bar graph showing this sample’s performance on the 
Delayed Memory domain compared to a normal distribution curve.  
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Figure 6. Bar graph showing this sample’s performance on 
the Overall Cognitive domain compared to a normal 
distribution curve. 
 
 
 
Comparison to General Population 
In order to evaluate the hypothesis that this sample will perform below the 
normative sample, the means of this sample’s performances on each subtest were 
compared to those of the general population, using subtest means established in the 
RBANS manual, which were derived from a standardized sample of 540 people. 
According to Welch t-test results, the mean scores on the list learning subtest were 
significantly lower in this sample population (M = 25.6, SD = 3.85) than in the general 
population (M = 28.45, SD = 4.48), t(41) = 3.165, p = .003. Mean scores on the figure 
copy subtest were also significantly lower in this sample population (M = 17.04, SD = 
2.11) than in the general population (M = 18.43, SD = 1.45), t(29) = 3.115, p = .004. See 
Table 6 below for all subtest means.  
 32 
Table 6 
Comparison of Sample Group Subtests to Normative Group means 
 Sample Group Normative Group 
Subtests Mean SD Mean SD 
List Learning* 25.6 3.85 28.45 4.48 
Story Memory 17.16 3.54 17.98 3.43 
Figure Copy* 17.04 2.11 18.43 1.45 
Line Orientation 16.76 3.27 16.3 2.95 
Picture Naming 9.68 0.63 9.53 0.8 
Semantic Fluency 21.64 5.45 21.1 4.58 
Digit Span 10.88 2.30 10.75 2.3 
Coding 47.88 10.22 49.68 8.43 
List Recall 5.60 2.08 6.45 2.0 
List Recognition 19.44 0.87 19.58 0.88 
Story Recall 8.68 2.48 9.35 2.05 
Figure Recall 12.80 3.58 14.18 3.38 
*comparison is significant at the .01 level 
 
In order to identify if these performances are significantly different from a mean 
index score of 100, one sample t-tests were performed, comparing the means of each 
domain of cognitive function against a test value of 100. The results of this analysis show 
that in this sample population, their mean performances on domains of visuospatial, 
immediate memory, and overall cognitive function were significantly lower than mean 
index scores. See Table 7 below.  
 
 
Table 7 
One-sample t-tests of Cognitive Domain Means Against a Test Value of 100  
Cognitive Domain t df p 
Mean 
Difference 95% C.I. 
Attention -.731 24 .472 -2.28000 -8.7152 4.1552 
Visuospatial* -.603 24 .552 -1.68000 -7.4315 4.0715 
Language -2.678 24 .013 -8.16000 -14.448 -1.8720 
Immediate Memory*  -2.713 24 .012 -7.80000 -13.733 -1.8671 
Delayed Memory -1.951 24 .063 -6.16000 -12.677 .3565 
Overall Cognitive Function* -2.827 24 .009 -7.24000 -12.525 -1.9548 
* significant at the 0.05 level  
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Cognitive Profile of this Population  
 
In order to create a cognitive profile of this sample, the mean index scores of each 
domain were evaluated. The graph below (Figure 7) depicts the overall performance of 
this sample. T-tests were utilized in order to identify if there was a significant difference 
between domains. There was no statistical difference domain by domain, but in 
conjunction with the above t-tests, the profile suggests higher scores on attention and 
language, and lower scores on visuospatial abilities, immediate memory, and overall 
cognitive function. 
 
 
 
Figure 7. Sample Performance on RBANS using Index Score Means  
 
 
 
Predictors of Cognitive Function 
 
The second hypothesis of this study was that lower income, fewer years of 
education, younger age at first drink, and more drinks per day would negatively affect 
each domain of cognitive function. Six stepwise linear regressions were run in order to 
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determine if these four variables predicted performance on each domain index of 
cognitive function: attention, language, visuospatial, immediate memory, delayed 
memory, and overall cognition. In four of the six analyses, years of education was the 
only significant predictor of cognitive functions, and entered into the regression 
equations. See Tables 8-11 below. Contrary to the hypothesis, income, age at first drink, 
and number of drinks per day were not significant predictors of cognitive functioning (p 
> .05). However, years of education was significantly related to: visuospatial ability, F (1, 
23) = 9.754, p = .005, indicating that approximately 30% of the variance of the 
visuospatial score could be accounted for by years of education; immediate memory, F 
(1, 23) = 4.536, p = .044, indicating that approximately 17% of the variance of the 
immediate memory score could be accounted for by years of education; delayed memory, 
F (1, 23) = 6.068, p = .022, indicating that approximately 21% of the variance of the 
delayed memory score could be accounted for by years of education; and overall 
cognitive function, F (1, 23) = 11.742, p = .002, indicating approximately 34% of the 
variance of the overall cognitive score could be accounted for by years of education. 
 
Table 8 
Linear Regression of Visuospatial Ability   
 B SE t p 95% C.I. 
Entered into Equation     Lower Upper 
  Education 3.784 1.212 3.123 .005 1.278 6.290 
Excluded from Equation     Partial Correlation 
  Income .016 - .086 .932 .018 
  Age at first drink .156 - .828 .416 .174 
  Drinks per day -.029 - -.151 .882 -.032 
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Table 9 
Linear Regression of Immediate Memory Ability   
 B SE t p 95% C.I. 
Entered into Equation     Lower Upper 
  Education 2.655 1.247 2.130 .044 .076 5.234 
Excluded from Equation     Partial Correlation 
  Income .089 - .449 .657 .095 
  Age at first drink -.170 - -.824 .419 -.173 
  Drinks per day .169 - .824 .419 .173 
 
 
 
Table 10 
Linear Regression of Delayed Memory   
 B SE t p 95% C.I. 
Entered into Equation     Lower Upper 
  Education 3.283 1.333 2.463 .022 .526 6.040 
Excluded from Equation     Partial Correlation 
  Income -.093 - -.484 .633 -.103 
  Age at first drink .031 - .152 .881 .032 
  Drinks per day -.144 - -.718 .480 -.151 
 
 
 
Table 11 
Linear Regression of Overall Cognitive Function   
 B SE t p 95% C.I. 
Entered into Equation     Lower Upper 
  Education 3.388 .989 3.427 .002 1.343 5.434 
Excluded from Equation     Partial Correlation 
  Income -.093 - -.528 .603 -.112 
  Age at first drink -.004 - -.024 .981 -.005 
  Drinks per day -.114 - -.619 .543 -.131 
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Predictors of Treatment Completion 
The third hypothesis of the study was that poor index scores on each domain of 
the cognitive assessment (RBANS) would have a negative effect on treatment 
completion. A preliminary analysis of bivariate correlations was conducted in order to 
assess the relationships between cognitive variables and completion. No variables were 
significantly correlated with treatment completion. See Table 12.  
 
 
Table 12 
Bivariate Correlations between Cognitive Domains and Completion  
Cognitive Domain 
Pearson 
Correlation 
Significance 
(2-tailed) 
Attention .003 .990 
Language .396 .050 
Visuospatial -.058 .782 
Immediate Memory  .159 .449 
Delayed Memory  .375 .065 
Overall Cognition  .238 .252 
 
 
Six hierarchical logistic regressions were conducted in order to investigate if any 
of the domains of cognitive function significantly predicted treatment completion, while 
controlling for education. In of these six models, years of education were entered in the 
first step, and each domain index score was entered in the second step. There were no 
significant effects of any of the domains on completion.  
In order to further investigate the effect of cognitive function on treatment 
completion, the cognitive domain index variables were transformed into dichotomous 
variables reflecting: below average, or average and above. A series of six hierarchical 
logistic regressions were then performed, with years of education in the first step, and 
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each dichotomous cognitive domain variable in the second step. According to these 
analyses, average and above delayed memory was a significant predictor of treatment 
completion, 2 (1) = 4.910, p = .027. See Table 13 below for coefficients.  
 
 
Table 13 
Hierarchical Logistic Regression Results Predicting Treatment Completion 
 B SE Wald p 95% C.I. 
     Lower Upper 
Years of Education .033 .246 .017 .895 .637 1.674 
Delayed Memory 2.112 1.014 4.343 .037 1.134 60.276 
 
 
 
Other Risk Factors and Treatment Completion 
The final hypothesis of this study was that a comorbid mental health diagnosis 
and dropout from prior rehabilitation treatments would have a negative effect on 
treatment completion. A preliminary frequency analysis indicated that 16 of the 25 
participants had a co-occurring diagnosed mental health condition. 15 of the 25 
participants had previously enrolled in an addiction treatment program, with 6 of them 
dropping out of treatment. Logistic regressions were used to evaluate the hypothesis 
regarding the effect of these variables on treatment completion. The first logistic 
regression evaluated whether a co-occurring mental health condition impacted treatment 
completion. The second logistic regression analyzed a subset of the original data, 
including only those who had previously enrolled in a treatment program. In this 
subdataset, a logistic regression evaluated whether prior dropout from treatment impacted 
current treatment completion. Neither variable significantly predicted treatment 
completion. See Tables 14 and 15.  
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Table 14 
Logistic Regression of Comorbid Mental Health on Treatment Completion   
 B SE Wald p 95% C.I. 
     Lower Upper 
  Mental Health -1.001 .947 1.118 .290 .057 2.351 
 
 
 
Table 15 
Logistic Regression of Prior Dropout on Treatment Completion   
 B SE Wald p 95% C.I. 
     Lower Upper 
  Prior Dropout -.693 1.080 .412 .521 .060 4.153 
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CHAPTER FIVE 
 
DISCUSSION 
 
 
This study examined cognitive deficits in the outpatient Chemical Dependency 
Partial Hospitalization Program at the Loma Linda University Behavioral Medical 
Center. There were a total of 25 patients who had a primary alcohol diagnosis recruited 
for this study during the months of May 2013 to March 2014.  
The purpose of this investigation was to identify the cognitive deficits present in 
this sample in order to understand the challenges that might be present in this type of 
population. Previous studies have suggested that chronic alcohol abuse has been linked to 
several cognitive deficits that affect aspects of everyday life, including learning, memory, 
abstracting, problem-solving, information processing (Parsons et al., 1998), spatial 
processing (Fein et al., 2006), decreased executive functioning (Glass et al., 2009), and 
impaired verbal fluency and decision making (Fernandez-Serrano et al., 2010). Other 
behavioral disturbances that occur with alcohol use include increased impulsivity and 
aggression (Bjork et al., 2004) and proneness to social deviance and disadvantageous 
decision-making (Fein et al., 2004). Further older age, lower education, health problems, 
psychiatric diagnoses, familial alcoholism, and duration of heavy drinking, have been 
inversely related to neuropsychological ability (Bates et al., 2006).  
 In this study, participants were given a brief neuropsychological battery, the 
repeatable battery for the assessment of neuropsychological status (RBANS). This 
measure uses twelve subtests to assess cognitive domains of attention, language, 
visuospatial ability, immediate memory, delayed memory, and yields an overall cognitive 
function score. An analysis of this sample’s subtest scores in comparison to a normative 
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sample indicated lower mean scores on the list learning and figure copy subtests, 
indicating lower performances on immediate verbal memory and visuospatial ability. 
Further, when this sample’s mean index scores were compared to an average index score 
of 100, analyses indicated lowered scores on visuospatial abilities, immediate memory, 
and overall cognitive function. These results are in agreement with previous research 
(mentioned above).  
 The next hypothesis of this study was that lower income, education, age at first 
drink, and higher severity of drinking (measured by number of drinks per day) would be 
inversely related with cognitive function. While this study did not entirely confirm these 
hypotheses, it did indicate that a higher number of years of education influenced higher 
rates cognitive functioning, which is not surprising. One reason the other hypotheses 
were not supported could in great part be due to the skewness of high income in this 
sample, with half of the participants making over $80,000, which is well over the average 
income of $61,000 in the US, according to the US Census Bureau. Further, given the 
small sample size, the range in age at first drink and number of drinks per day may not 
have been sufficient in detecting a relationship with cognitive function.  
Another goal of this study was to examine variables that may be negatively 
related to treatment completion. In the addiction treatment program at the Loma Linda 
Behavioral Medical Center, of the 25 patients recruited, 16 (64%) patients completed 
treatment. This is consistent with previous studies, which report completion rates of 
65.2% (Fishman et al., 1999), and attrition rates of 10-30% (Rabinowitz and Marjefsky, 
1998). This study hypothesized that lower cognitive function would predict lower levels 
of treatment completion, as previous research has suggested (Aharonovich et al., 2006; 
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Teichner et al., 2002). While the index scores of the domains of cognitive function did 
not significantly predict treatment completion, the analysis comparing completion rates 
of those with below average scores to those with average or above delayed memory 
scores yielded a result indicating that below average delayed memory scores negatively 
impacted treatment completion. The most direct explanation for this finding is that those 
with poor delayed memory may find it more difficult to carry over information learned 
during their treatment program, directly influencing their motivation to remain in 
treatment. With such strong biological and social drives to return to alcohol use, if one 
cannot remember the reasons to abstain, treatment compliance may become too difficult. 
It is highly likely that the other domains were not predictive of treatment completion due 
to insufficient sample size.  
 The last hypothesis of this study was that other risk variables, such as comorbid 
mental health diagnoses and/or previous dropout from treatment would impact treatment 
completion rates. Again, this study did not uphold this hypothesis. This could be due to 
insufficient sample size, or may suggest that there are other more relevant factors that 
influence treatment completion. Investigating symptomatology related to mental health 
diagnoses may prove to be more relative to treatment completion than the diagnosis itself.  
 
Limitations 
 The present study has a number of limitations. First off, the sample size recruited 
for this study was very small (n = 25). With a sample of this size, options for data 
analyses are not only limited, but are poorly utilizable in establishing significant 
relationships between variables. The data regarding alcohol use history should have been 
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more specific. For example, the interview should have ascertained how many years each 
participant struggled with alcohol abuse versus years of subclinical alcohol use. Further, 
the neuropsychological test use, chosen for its short administration time, which was 
determined by the treatment program, is not as sensitive as one would need for an 
investigation of this nature. A more comprehensive battery, including individual tests for 
each domain of cognitive function would be much more appropriate. The ideal battery, 
while still accounting for participant effort and time considerations, would include the 
Wechsler Adult Intelligence Scale IV - Digit Span subtest, Trail Making Test A & B, 
Controlled Oral Word Association tests of Semantic and Phonemic Fluency, California 
Verbal Learning Test II, Rey Figure Copy Test, Wechsler Memory Scale IV – Logical 
Memory and Visual Reproduction Subtests, and Wisconsin Card Sorting Test. Beck 
Depression Inventory and Beck Anxiety Inventory would also be relevant.    
 
Clinical Implications 
With these limitations established, it is important to note that this study is still 
innovative and fully applicable to the clinical setting at hand. This is the first study 
conducted at the Loma Linda BMC that has evaluated cognitive function in their 
treatment population. Further, given that half of this sample scored below average on 
overall cognitive function, it suggests an area in which program development could 
identify as an area of focus. Utilizing this data, the staff and counselors can immediately 
start to apply this knowledge to the treatment program. Baseline cognitive assessments 
can be helpful in identifying those with cognitive deficits, who may be at higher risk of 
dropping out of treatment. If the treatment staff can target and engage these patients, they 
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may be able to keep them in treatment longer. With studies showing that longer time in 
treatment directly impacts future abstinence (Moos et al., 1995), this can be a very 
important clinical factor.  
 
Research Implications and Future Directions 
 
 In regards to research implications, this study shows that there may be factors that 
affect treatment completion that have not yet been investigated. It will be important to 
identify what these factors are in order to improve treatment, and its direct influence on 
future abstinence. This study may also generate a need to evaluate site-specific treatment 
programs, in order to identify risks for treatment dropout. Further, it may suggest that 
individually tailored treatment plans are even more important to treatment, as patients 
with different cognitive deficits and associated symptoms may benefit from different 
types of interventions.  
 In regard to future directions, this study has incorporated a repeated measures 
protocol, in which participants are being given a cognitive assessment at baseline, and 
also at the end of their treatment. This will allow our researchers to investigate whether 
participant’s cognitive function changes over time, and in what way. By identifying 
deficits that improve, remain constant, or decrease over time, we can theoretically 
implement cognitive remediation strategies into the treatment protocol that can directly 
address cognitive deficits, and aspire to improve treatment completion rates.  
 
Conclusion 
  In summary, this study aimed to identify cognitive deficits in the addiction 
 44 
treatment population at the Loma Linda Behavioral Medical Center. According to 
previous research and literature, cognitive deficits related to learning, memory, 
abstracting, problem-solving, information processing (Parsons et al., 1998), spatial 
processing (Fein et al., 2006), decreased executive functioning (Glass et al., 2009), and 
impaired verbal fluency and decision making (Fernandez-Serrano et al., 2010) were all 
found to be associated with alcohol use and abuse. Although not all of these findings 
were not replicated in this population, there were trends in this sample’s data that 
suggested reductions in visuospatial abilities, immediate memory, delayed memory, and 
overall cognitive function. Further, it was found that below average scores on delayed 
memory significantly predicted treatment dropout. This discovery can be utilized in this, 
and all, treatment populations, as cognitive deficits can directly impact a patient’s 
engagement in and completion of treatment. By identifying those with memory 
difficulties as having a lower rate of treatment completion, staff and counselors can target 
these patients in order to deepen their engagement in treatment. By retaining these 
patients in treatment longer, not only could the LLUBMC’s chemical dependency 
treatment program have higher rates of completion, these patients may show benefits of 
longer rates of abstinence after finishing treatment. Further, other risk factors such as 
lower income, younger age at first drink, and drinking severity as they related to 
cognitive function were investigated; however, the results did not support they study 
hypotheses. This may have been in part due to small sample size, undetectable range in 
prevalence, or simply that these variables are not significantly predictive of cognitive 
function. Comorbid mental health diagnoses and prior treatment dropout were also 
examined as they related to treatment completion. Again, while the findings of this study 
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did uphold the study hypotheses, this may be due to small sample size or poor range in 
variable data. This suggests a need for continued research in this area and further 
investigation into factors that effect treatment completion. By identifying these factors, 
treatment programs may be able to target patients who are at risk for not completing 
treatment. By targeting at risk patients, treatment programs may be able to increase 
treatment retention rates, improve treatment completion, and in turn, reduce national rates 
of addiction relapse in the future.  
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APPENDIX A 
 
PARTICIPANT INFORMATION SURVEY 
 
 
 
 
 
 
 
Today’s Date__________________________________    
 
Demographic Questions 
 
1. Date of Birth:  (mm/dd/yyyy) ______/______/__________ 
 
2. Gender:  Male/Female   (circle one)  
 
3. What city do you live in?  
 
City: ______________________________________  
 
4. Approximately how long have you lived at this address? (Years/Months) 
_____________________ 
 
5. Race/Ethnicity: (please check one) 
 
_____ Caucasian 
_____ Hispanic 
_____ African-American/Black 
_____ Asian 
_____ Other (specify) ____________________________ 
 
6. What is your marital status:  
[   ]1    Married 
[   ]2    Remarried 
[   ]3    Widowed 
[   ]4    Separated 
[   ]5   Divorced 
[   ]6 Single, never married  
 
7. What is your highest level of education? 
 [   ]1   Grade School or Less Education 
 [   ]2    High school diploma or equivalent (trade school certificate) 
 [   ]3    Some college or Vocational, Business or Trade School 
 [   ]4    Associate or Bachelors college degree 
NAME (first and last name): 
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 [   ]5    Masters or Doctoral degree 
 
8. Do you have a profession, trade, or skill? ____________________________ 
 
9. What is your employment status? 
a. Employed full time 
b. Employed part time 
c. Student 
d. Unemployed 
 
10. What type of health insurance do you currently have? 
[   ]1    I don’t have any health insurance 
 [   ]2    Private Insurance, Blue Cross, HMO 
 [   ]3    Medicare/Medicaid/Medical 
 [   ]4     Champus/ Champus VA/other military 
 [   ]5    Other type of insurance: 
 
11. What is your average household income? 
a. <10,000 
b. 10,000-<35,000 
c. 35,000-<60,000 
d. 60,000-<80,000 
e. 80,000+ 
  
 
Drug and Alcohol history questions 
 
12. Have you previously been in treatment prior for alcohol addiction or drug rehab? 
No, skip to question 16 
Yes 
 
13. How many times previously have you been in treatment for alcohol addiction or 
drug rehab?___________________  
 
14. Did you terminate any of the previous treatments early? 
  No, skip to question 16 
  Yes 
 
15. Why did you choose to terminate the previous treatments early? 
__________________________________________________________________ 
  
16. At what age did you begin drinking alcohol? ___________________ 
 
17. On average, how many drinks do you have per day? ___________________ 
 
18. On average, how many drinks do you consume in one sitting? _____________ 
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19.  Are there any other drugs you take either regularly or even on occasion? 
 
a. Heroin: (#times)__________________ (#years)_______________________ 
b. Methadone: (#times)_______________ (#years)_______________________ 
c. Benzodiazepines (Xanax, Valium, etc.): (#times)_______ (#years)_________ 
d. Cocaine: (#times)__________________ (#years)_______________________ 
e. Amphetamines (meth, speed, etc.): (#times)_________ (#years)___________ 
f. Cannabis:  (#times)________________ (#years)_______________________ 
g. Hallucinogens (LSD, PCP, mushrooms, etc.): (#times)_____ (#years)______  
h. Inhalants: (#times)__________________(#years)_______________________ 
 
20. When was the last time that you had any alcohol or took drugs, other than the 
medications given to you in treatment?_______________________ 
 
21. How important is it for you to complete treatment for your alcohol/drug 
problems?  (0-5; 0:not at all, 5:extremely important) ____________ 
 
 
General Health Questions 
 
22. Have you ever had an injury to your brain? (like concussion, trauma..etc.) 
No 
  Yes, please specify________________________________________ 
 
23. Are you being treated for any medical illness at this time?  
No 
Yes, please specify_________________________________________ 
 
24. Have you ever been diagnosed with a chronic medical illness? (like cancer, 
diabetes, etc.)  
No 
Yes, please specify_________________________________________ 
 
25. Have you ever been diagnosed with a mental health condition (like depression, 
bipolar…etc.) 
No 
  Yes, please specify_________________________________________ 
 
26. Have you ever been diagnosed with a learning disability? (like ADHD, reading 
disability, writing disability, etc.)  
No 
Yes, please specify_________________________________________ 
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27. Are you currently taking any medication? 
 No 
  Yes, please specify_________________________________________ 
 
 
 
Stress  
 
28. What do you feel is your current stress level on a scale of 0-10 with 10 the worst 
and 0 no stress at all? 
 
 
Legal History  
 
29.  Was this admission prompted by the criminal justice system?  
No 
Yes, please specify_________________________________________ 
 
30.  Are you on probation or parole?  
No 
Yes 
 
 
Family History  
 
31.  Do you have any relatives that have/had a significant drinking or drug use 
problem?  
a. Mother 
b. Grandmother 
c. Grandfather 
d. Uncle 
e. Aunt 
 
f. Father 
g. Grandmother 
h. Grandfather 
i. Uncle 
j. Aunt 
 
k. Siblings 
 
 
 
 
